Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion type Assertion NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_head.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion description "[Because aberrant methylation of ppENK or p16 was more often detected in similar grade PanINs from patients with pancreatic carcinoma than in those with other pancreatic diseases, it may be a useful indicator of the potential malignancy of epithelial cells of the pancreas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_provenance.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion evidence source_evidence_literature NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_provenance.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion SIO_000772 12000709 NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_provenance.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion wasDerivedFrom befree-20150227 NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_provenance.
- NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_assertion wasGeneratedBy ECO_0000203 NP615966.RA51-txXaPe2m6onTIZ6jqsdk0Vxbu279Mne8vIwW-NT0130_provenance.